Authum Invests ₹36 Cr in Rivaara Labs

  Published 10 months ago

Authum Investment plans Rs 36 crore CCPS infusion and Rs 56.83 lakh purchase for Rivaara Labs' growth.

  • Rivaara Labs operates pathology, imaging, PCR testing, and genomic sequencing diagnostic service centres across India
  • Investment includes Rs 36 crore for 3.6 crore CCPS, plus Rs 56.83 lakh for acquiring existing securities of equity and convertible
  • Authum Investment focuses on loan provision, share trading, and strategic investments for a sustainable growth future

You might like these

Varun Bev Buys Stake in Sri Lankan Visi, Cooler Firm

AC Stocks Surge Ahead of GST Meet

BP's Financial Struggles & Future Reset

Aadhar Housing Q1 Profit Jumps 19%

SEBI Chair: PIDs Must Lead Public Interest

Rallis India Q1 Profit Doubles

Adani Group Faces US Sanctions Probe

News that matters the most ⚡